Search
Portfolio
SGX
Google
Yahoo
TradingView
CHINA MEDICAL SYSTEM HLDGS LTD (8A8)
SGD 1.75
+0.00% +0.00
Portfolio
Watchlist
Div
Anns
News
Info
Trans
Note
All
Financial
Buy Back
Insider Trading
CMS
2026-04-23
REPL::Annual General Meeting::Voluntary
CMS
2026-04-23
General Announcement::NDA for Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China
CMS
2026-04-01
Annual General Meeting::Voluntary
CMS
2026-04-01
Annual Reports and Related Documents::
CMS
2026-04-01
Annual Reports and Related Documents::
CMS
2026-03-31
General Announcement::Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
CMS
2026-03-16
General Announcement::The Nomination Committee Terms of Reference
CMS
2026-03-16
General Announcement::LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
CMS
2026-03-16
Cash Dividend/ Distribution::Mandatory
CMS
2026-03-16
Financial Statements and Related Announcement::Full Yearly Results
CMS
2026-03-13
General Announcement::New Drug for Renal Anaemia Desidustat Tablets Approved in China
CMS
2026-03-04
General Announcement::Approval of Drug Clinical Trials for Overweight/Obesity Indication of Self-Developed Drug CMS-D008
CMS
2026-03-04
General Announcement::Notice of Board Meeting
CMS
2026-03-02
General Announcement::Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
CMS
2026-02-24
General Announcement::NDA for Additional Indication AD for Ruxolitinib Cream Accepted and Granted Priority Review in China
CMS
2026-02-12
General Announcement::Signing of Exclusive Distribution Agreement for the Original Drug Lidoderm Lidocaine Cataplasms
CMS
2026-02-03
General Announcement::Approval of Drug Clinical Trials for CMKD Indication of Innovative Drug CMS-D017
CMS
2026-02-02
General Announcement::Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
CMS
2026-01-30
General Announcement::Approval of Clinical Trials for PNH of Innovative Drug Complement Factor B Inhibitor CMS-D017
CMS
2026-01-30
General Announcement::New Drug Application of Ruxolitinib Phosphate Cream Approved in China
CMS
2025-12-31
General Announcement::Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
CMS
2025-12-15
General Announcement::Innovative Oral JAK1 Inhibitor Povorcitinib Included In The List Of Breakthrough Therapeutic Drugs
CMS
2025-12-11
General Announcement::New Drug Application of Class 1 Innovative Drug Y-3 for Injection for AIS Accepted in China
CMS
2025-12-01
General Announcement::Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
CMS
2025-10-31
General Announcement::Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
CMS
2025-10-30
General Announcement::NDA for AD Indication of Anti-IL-4Ra Humanized Monoclonal Antibody Injection Accepted in China
CMS
2025-10-27
General Announcement::Signing a Distribution Agreement for Ophthalmic Drugs Lucentis and Beovu
CMS
2025-09-30
General Announcement::Approval of Drug Clinical Trials for Additional COPD Indication of Class 1 MG-K10 Injection
CMS
2025-09-30
General Announcement::Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
CMS
2025-09-28
General Announcement::Approval of Phase III Drug Clinical Trials for Chronic Spontaneous Urticaria Indication of MG-K10
CMS
2025-09-26
General Announcement::Positive Results from Phase 3 Clinical Trial of Ruxolitinib Cream in Chinese Patients with AD
CMS
2025-09-26
General Announcement::Approval of Drug Clinical Trials for Uterine Fibroids Indication of Innovative Drug CMS-D002
CMS
2025-09-22
General Announcement::Signing Collaboration Agreements for Vecantoxatug Injection and Silevimig Injection
CMS
2025-09-02
General Announcement::NOTIFICATION LETTER ON ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS
CMS
2025-09-02
General Announcement::REMINDER LETTERS ON THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS
CMS
2025-09-02
Annual Reports and Related Documents::
CMS
2025-09-01
General Announcement::Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
CMS
2025-08-28
General Announcement::Approval of Clinical Trials for Vitiligo and Hidradenitis Suppurativa Indications of Povorcitinib
CMS
2025-08-18
General Announcement::LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
CMS
2025-08-18
Cash Dividend/ Distribution::Mandatory
CMS
2025-08-18
Financial Statements and Related Announcement::Half Yearly Results
CMS
2025-08-06
General Announcement::Notice of Board Meeting
CMS
2025-08-01
General Announcement::Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
CMS
2025-07-28
General Announcement::New Drug Application for Improved New Drug ZUNVEYL Accepted in China
CMS
2025-07-15
General Announcement::SUCCESSFUL SECONDARY LISTING ON THE SINGAPORE EXCHANGE
CMS
2025-07-14
General Announcement::EXPECTED LISTING DATE FOR THE PROPOSED SECONDARY LISTING ON THE SINGAPORE EXCHANGE
CMS
2025-07-14
Equity - Listing Confirmation::Admission to the Mainboard of the SGX-ST
© 2026 Dividends.sg